MMP2 and colorectal carcinoma: As neither batimastat nor the specific MMP2/9 inhibitor III led to any relevant cytotoxicities in our CRC cells, which is in accordance with previous literature [17], inhibitors were used at concentrations that efficiently reduced protein expression levels (data not shown).